The mitochondrial uncoupling protein‐2 is a master regulator of both M1 and M2 microglial responses. (3rd August 2015)

• Record Type: Journal Article
• Authors: De Simone, Roberta; Ajmone‐Cat, Maria Antonietta; Pandolfi, Manuela; Bernardo, Antonietta; De Nuccio, Chiara; Minghetti, Luisa; Visentin, Sergio
• Is Part Of: Journal of neurochemistry. Volume 135:Number 1(2015:Oct.)
• Page Start: 147
• Page End: 156
• Publication Date: 2015-08-03
• Subjects: Neurochemistry -- Periodicals; 616.8042
• DOI: 10.1111/jnc.13244
• Languages: English
• ISSNs: 0022-3042

Abstract

<abstract abstract-type="main" id="jnc13244-abs-0001"> <title>Abstract</title> <sec id="jnc13244-sec-1001" sec-type="section"> <p>Microglial activation is a dynamic process, central to neuroinflammation, which can have beneficial or pathogenic effects to human health. Mitochondria are key players in neuroinflammatory and neurodegenerative processes, common to most brain diseases. To the best of our knowledge on the role of mitochondria in the modulation of neuroinflammation, we focused on the mitochondrial uncoupling protein‐2 (UCP2), known to control mitochondrial functions and to be implicated in a variety of physiological and pathological processes. In primary microglial cultures, the M1 stimulus lipopolysaccharide induced an early and transitory decrease in UCP2 levels. The initial UCP2 down‐regulation was paralleled by mitochondrial inner membrane potential (mMP) depolarization and increased mitochondrial reactive oxygen species production. The key role of UCP2 in controlling mMP and reactive oxygen species production was confirmed by both pharmacological inhibition and down‐regulation by RNA interference. Additionally, UCP2‐silenced microglia stimulated with lipopolysaccharide showed an enhanced inflammatory response, characterized by a greater production of nitric oxide and interleukin‐6. UCP2 was differently regulated by M2 stimuli, as indicated by its persistent up‐regulation by interleukin‐4. In UCP2‐silenced microglia, interleukin‐4 failed to induce M2 genes (mannose receptor 1 and interleukin‐10) and to reduce M1 genes (inducible nitric oxide synthase and tumour necrosis factor‐α). Our findings indicate that UCP2 is central to the process of microglial activation, with opposite regulation of M1 and M2 responses, and point to UCP2 manipulation as a potential strategy for redirecting microglial response towards protective phenotypes in several brain diseases where neuroinflammation is recognized to contribute to neurodegeneration.</p> </sec> <sec id="jnc13244-sec-1002" sec-type="section"> <p> <boxed-text content-type="graphic" id="jnc13244-blkfxd-0101" position="anchor" orientation="portrait"> <graphic position="anchor" mimetype="image" xlink:href="ark:/27927/pgj2xsv0fp1" orientation="portrait" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink" /> </boxed-text> We show that the mitochondrial uncoupling protein‐2 (UCP2) is central to the process of microglial activation, with opposite regulation of M1 and M2 responses. In UCP2‐silenced microglia, lipopolysaccharide (LPS) triggers an enhanced inflammatory response characterized by a greater expression of M1 genes, whereas interleukin‐4 (IL‐4) fails in inducing M2 genes and reducing M1 genes. We propose UCP2 manipulation as a potential strategy for redirecting microglial response towards protective phenotypes.</p> </sec> </abstract>